Teddy123
commented on
$Wheeler Real Estate Investment Trust Inc (WHLR.US)$ one day show over ???
1
$Autonomix Medical (AMIX.US)$
The finalization of the ASIC microchip design marks a important technical advancement in Autonomix's nerve-sensing catheter development. The proprietary chip enables detection of minute nerve signals through blood vessels - a significant technical challenge that has historically intravascular neuromodulation approaches. The successful completion of both in vivo preclinical testing and bench testing validates the chip's fundamental capabilities....
The finalization of the ASIC microchip design marks a important technical advancement in Autonomix's nerve-sensing catheter development. The proprietary chip enables detection of minute nerve signals through blood vessels - a significant technical challenge that has historically intravascular neuromodulation approaches. The successful completion of both in vivo preclinical testing and bench testing validates the chip's fundamental capabilities....
$ParaZero Technologies (PRZO.US)$
This regulatory milestone could be a significant catalyst for ParaZero's market position. With a modest market cap of $20.87 million, this approval potentially opens doors to substantial defense contracts. The defense sector typically offers higher margins and longer-term contracts compared to commercial markets, which could significantly impact the company's revenue trajectory.
The HALO system's compatibility with commercial drone platfo...
This regulatory milestone could be a significant catalyst for ParaZero's market position. With a modest market cap of $20.87 million, this approval potentially opens doors to substantial defense contracts. The defense sector typically offers higher margins and longer-term contracts compared to commercial markets, which could significantly impact the company's revenue trajectory.
The HALO system's compatibility with commercial drone platfo...
$NAYA Biosciences (NAYA.US)$
The gross proceeds from the offering, before deducting placement agent’s fees and other offering expenses, are expected to be approximately $9.5 million. The Company intends to use the net proceeds from this offering to fund an installment towards the purchase price of the Wisconsin Fertility Institute, to redeem 4,000 shares of our Series C-2 preferred stock with a stated value of $4,000,000, towards outstanding debt obligations that are or will become payable u...
The gross proceeds from the offering, before deducting placement agent’s fees and other offering expenses, are expected to be approximately $9.5 million. The Company intends to use the net proceeds from this offering to fund an installment towards the purchase price of the Wisconsin Fertility Institute, to redeem 4,000 shares of our Series C-2 preferred stock with a stated value of $4,000,000, towards outstanding debt obligations that are or will become payable u...
Teddy123 : Hopefully another run